Bioactive fragment of human IL-1β [163-171] modulates the immune response to synthetic peptides of HIV

Microbiology and Immunology

Volumn 41, Issue 12, 1997, Pages 965-974

  Gokulan, Kuppan ^a,b   Rao, D Nageswara ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Chimeric immunogen; HIV peptides; Interleukin 1

Indexed keywords

ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN G2A; INTERLEUKIN 1BETA[163-171]; INTERLEUKIN 2; PHYTOHEMAGGLUTININ; SYNTHETIC PEPTIDE;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE ACTIVATION; BIOASSAY; CELLULAR IMMUNITY; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; IMMUNOMODULATION; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; SECONDARY IMMUNE RESPONSE; T LYMPHOCYTE ACTIVATION;

EID: 0031473109     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.1997.tb01956.x     Document Type: Article

References (25)

1. Anderson, P.M., Ewards, K.E., Insel, R., and Porch, C.R. 1987. Priming and induction of Haemophilus influenza type b capsular antibodies in early infancy by gp120, and oligosaccharide-protein conjugate vaccines. J. Pediatric. 111: 644-650.
2. Antoni, G., Presentini, R., Perin, F., Tagliabue, A., Ghiara, P., Censini, S., Volpini, G., Villa, L., and Borachi, D. 1986. A short synthetic peptide fragment of human interleukin-1 with immunosumulatory but not inflammatory activity. J. Immunol. 137: 3201-3204.
3. Avrameas, S., and Ternynck, T. 1969. The cross linking of proteins with glutaraldehyde and its use for the preparation of immunosorbents. Immunochemistry 6: 43-47.
4. Backers, W., Villa, L., Gonfloni, S., Castagonli, L., Newton, S.M., Cesareni, G., and Ghiara, P. 1992. Increasing the immunogenicity of protein antigens through the genetic insertion of VQGEESNDK sequence of human IL-1β into their sequence. J. Immunol. 51: 1757-1760.
5. Berman, P.W., Matthews, T.J., Riddle, L., Champe, M., Hobbs, M.R., Nakamura, G.R., Mercer, J., Eastman, D.J., Lucas, C., Langlois, A.J., Wurm, F.M., and Gregory, T.J. 1992. Neutralization of multiple laboratory and clinical isolates of human immunodeficiency virus type 1 (HIV-I) by antisera raised against gp120 from the MN isolate of HIV-I. J. Virol. 66: 4464-4469.
6. Boraschi, D., Ghiara, P., Scapigluasi, G., Villa, L., Sette, H., and Tagliabue, A. 1992. Binding and internalization of the 163-171 human IL-1β. Cytokines 4: 201-204.
7. Clerici, M., Hakim, F.T., Venzon, D.J., Blatt, S., Hendrix, C.W., Wynn, T.A., and Shearer, G.M. 1993. Changes in interleukin-2 and interleukin-4 production in asymptomatic human immunodeficiency virus-seropositive individuals. J. Clin. Invest. 91: 759-765.
8. Durum, S.K., Schmidt, J.A., and Oppenheim, J.J. 1985. Interleukin-1; an immunological perspective. Annu. Rev. Immunol. 3: 263-287.
9. Frasca, D., Boraschi, D., Baschieri, S., Bossu, P., Tagliabue, A., Adorini, L., and Doria, G. 1988. In vivo restoration of T-cell function by human IL-1β or its 163-171 nonapeptide in immunodepressed mice. J. Immunol. 141: 2651-2655.
10. Gallo, R.C., Salahuddin, S.Z., Popovic, M., Shearer, G.M., Kaplan, M., Haynes, B.F., Palker, T.J., Redfield, R., Oleske, J., and Safai, B. 1984. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224: 500-503.
11. Gokulan, K., Tripathi, S.P., and Rao, D.N. 1997. Advantage of dimeric peptide antigens in serodiagnosis of HIV infection. Microbiol. Immunol. 41: 215-220.
12. Golding, H., Robey, F.A., Gates, F.T., Lider, W., Beining, P.R., Hoffman, T., and Golding, B. 1988. Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II-b1. Monoclonal antibodies against the gp41 derived peptides and patients sera react with native HLA class II antigens, suggesting a role of autoimmunity in the pathogenesis of acquired immune deficiency syndrome. J. Exp. Med. 166: 914-923.
13. Goudsmit, J., Debouck, C., Meloen, R.H., Smit, L., Bakker, M., Asher, M.B., Wolff, A.V., Gibbs, C.J., Jr., and Gajdusek, D.C. 1988. Human immunodeficiency virus type-I neutralization epitope with conserved architecture elicits type-specific antibodies in experimentally infected chimpanzees. Proc. Natl. Acad. Sci. U.S.A. 185: 4478-4482.
14. 5 I. Effects of carrier, copolymer adjuvants and lipopolysaccharide on isotype selection. J. Immunol. 146: 3583-3590.
15. Kironde, F.A.S., Rao, K.V.S., Saha, S., and Sahoon, N. 1991. Towards the design anti-malaria vaccines; a hybrid immunogen capable of eliciting immune responses to epitopes of circumsporozoite antigens from two different species of malaria parasite, Plasmodium. Immunology 74: 323-338.
16. Lowenthal, J.W., Cerottini, J.C., and Mac Donald, H.R. 1986. Interleukin-1 dependent induction of both interleukin-2 secretion and IL-2 receptor expression by thymoma cells J. Immunol. 137: 1226-1231.
17. Muegge, K., Williams, T.M., Kant, J., Karin, M., Chiu, R., Schmidt, A., Siebenlist, U., Young, H.A., and Durum, S.K. 1989. Interleukin-1 costimulatory activity on the interleukin-2 promotor via AP-1. Science 246: 249-251.
18. Nara, P.L., Garrity, R.R., and Goudsnmit, J. 1991. Neutralization of HIV-I: a paradox of humoral proportions. FASEB J. 5: 2437-2455.
19. Nencioni, L., Villa, L., Tagliabue, A., Antoni, G., Presentini, R., Perin, F., Silvestri, S., and Boraschi, D. 1987. In vivo immunostimulating activity of the 163-171 peptide of human IL-1β. J. Immunol. 139: 800-804.
20. Rao, K.V.S., and Nayak, A.R. 1990. Enhanced immunogenicity of a sequence derived from hepatitis B virus surface antigen in a composite peptide that includes the immunostimulatory region from human interleukin-1. Proc. Natl. Acad. Sci. U.S.A. 87: 5519-5522.
21. Robinson, E.W., Jr., Kawamura, T., Grony, M.K., Lake, D., Xu, J.-Y., Matsumoto, Y., Sugano, T., Masuho, Y., Mitchell, Y.W., Hersh, E., and Pazner, S.Z. 1990. Human monoclonal antibodies to the human immunodeficiency virus type-I (HIV-I) transmembrane glycoprotein gp41 enhance HIV-I infection in vitro. Proc. Natl. Acad. Sci. U.S.A. 87: 3185-3189.
22. Schmilz, J., Assenmacher, M., and Radbruch, A. 1993. Regulation of T helper cell cytokine expression: functional dichotomy of antigen-presenting cells. Eur. J. Immunol. 23: 191-199.
23. Sinigaglia, E. Guttinger, M., Kilgus, J., Doran, D.M., Matile, H., Etlinger, H.M., Trzeciak, A., Gillessen, D., and Pink, J.R.L. 1988. A malaria T-epitope recognized in association with most mouse and human MHC class-II molecules. Nature 336: 778-780.
24. Snapper, C.M., and Paul, W.E. 1987. Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236: 944-947.
25. Wit, D.D., Mechelen, M.B., Ryelandt, M., Figuairedo, A.C., Abramowicz, D., Goldman, M., Bazin, H., Urbain, J., and Leo, O. 1992. The injection of deaggregated γ-globulins in adult mice induces antigen-specific inresponsiveness of T helper type-I but not type-2 lymphocytes. J. Exp. Med. 175: 9-14.